Clinical trials
Sleep Initiation and Maintenance Disorders trials in Hong Kong with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Unknown status | 15 |
| Recruiting | 12 |
| Not yet recruiting | 11 |
| Suspended | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 40 |
| Chinese University of Hong Kong | 19 |
| The Hong Kong Polytechnic University | 16 |
| College of Professional and Continuing Education Limited | 1 |
| Education University of Hong Kong | 1 |
| Hong Kong Metropolitan University | 1 |
| Hospital Authority, Hong Kong | 1 |
| Neurovalens Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Initiation and Maintenance Disorders | 80 |
| Parasomnias | 6 |
| Anxiety Disorders | 4 |
| Attention Deficit Disorder with Hyperactivity | 4 |
| Sleep Wake Disorders | 3 |
| Breast Neoplasms | 2 |
| Neoplasms | 2 |
| Stroke | 2 |
| Autism Spectrum Disorder | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.